Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1164/ajrccm.162.1.16213c | DOI Listing |
Trials
October 2020
Community and Family Medicine, AIIMS Rishikesh, Rishikesh, India.
Objectives: 1. To compare the safety and efficacy of Hydroxychloroquine with Ribavirin and standard treatment in patients with non-severe COVID-19 infection 2. To compare the safety and efficacy of standard treatment, Lopinavir-ritonavir with Ribavarin, and Hydroxychloroquine with Ribavirin in patients with severe COVID-19 infection TRIAL DESIGN: The study is an Open label, Parallel arm design, stratified randomised controlled trial.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!